BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Companyâs ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
äŒæ¥ã³ãŒãBLFS
äŒç€ŸåBioLife Solutions Inc
äžå Žæ¥Nov 22, 1989
æé«çµå¶è²¬ä»»è
ãCEOãDe Greef (Roderick)
åŸæ¥å¡æ°159
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Nov 22
æ¬ç€Ÿæåšå°Suite 310
éœåžBOTHELL
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·98021
é»è©±çªå·14254011400
ãŠã§ããµã€ãhttps://www.biolifesolutions.com/
äŒæ¥ã³ãŒãBLFS
äžå Žæ¥Nov 22, 1989
æé«çµå¶è²¬ä»»è
ãCEOãDe Greef (Roderick)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã